Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.

Funmi Ford, 39, shared the moment she called her two sons, Sammy, then 6, and Solly, then 3, upstairs because they were being "too quiet." The Birmingham, Alabama-based content creator had no idea ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...

Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has ...

In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.

Hims & Hers (NYSE:HIMS) provides a telehealth platform offering prescription and non-prescription health and wellness ...

Hims, Inc. is a telehealth company, primarily targets men's wellness and healthcare. The company offers treatments for issues like hair loss and erectile dysfunction. Hims leverages online ...